To ascertain the annual incidence rate and the clinical features, other than visual outcome, of idiopathic intracranial hypertension (IIH) in Parma, northern Italy.
METHODS
Neurologic care of people living in the Parma area is entirely provided by one private and two public hospitals. Medical records related to IIH were retrospectively reviewed for all Parma residents from 1990 through 1999.
Results
Ten patients (8 women and 2 men) were identified as having IIH according to modified Dandy criteria. Their age ranged from 16 to 53 years with a mean of 36 years at diagnosis. The annual age-adjusted rate per 100,000 is 0.28 for the total population. For women in reproductive age, the annual incidence rate is 0.65/100,000. For overweight women in reproductive age, the annual incidence rate is 2.7/100,000.
CONCLUSIONS
The incidence rate found in this study is lower than the incidence reported in previous US and Libyan studies. A significant difference in overweight distribution is observed comparing percentage of body weight between US and Parma populations. As overweight and obesity are important factors contributing to IIH development, it is possible that their low percentage in the Parma population may, at least partially, explain the low IIH incidence observed.
LeeA.G., GolnikK., KardonR.Sleep apnea and intracranial hypertension in men.Ophthalmology2002; 109: 482–5.
20.
IrelandB., CorbettJ.J., WallaceR.B.. The search for causes of idiopathic intracranial hypertension. A preliminary case-control study.Arch Neurol1990; 47: 315–20.
21.
GiuseffiV., WallM., SiegelP.Z., RojasP.B.. Symptoms and disease associations in idiopathic intracranial hypertension (pseudotumor cerebri). A case-control study.Neurology1991; 41: 239–44.
22.
WallM., GeorgeD.. Visual loss in pseudotumor cerebri. Incidence and defects related to visual field strategy.Arch Neurol1987; 44: 170–5.
23.
WallM., GeorgeD.. Idiopathic intracranial hypertension. A prospective study of 50 patients.Brain1991; 114: 155–80.
24.
CorbettJ.J., SavinoP.J., ThompsonH.S.Visual loss in pseudotumor cerebri: follow-up of 57 patients from 5 to 41 years and a profile of 14 patients with permanent severe visual loss.Arch Neurol1982; 39: 461–74.
25.
DurcanJ.F., CorbettJ.J., WallM.. The incidence of pseudotumor cerebri. Population studies in Iowa and Louisiana.Arch Neurol1988; 45: 875–7.
26.
RadhakrishnanK., SridharanR., AshokP.P., MousaM.E.. Pseudotumor cerebri: incidence and pattern in North-Eastern Libya.Eur Neurol1986; 25: 117–24.
RadhakrishnanK., ThackerA.K., BohlagaN.H., MalooJ.C., GerryoS.E.. Epidemiology of idiopathic intracranial hypertension: a prospective and case-control study.J Neurol Sci1993; 116: 18–28.
29.
KeslerA., GadothN.. Epidemiology of idiopathic intracranial hypertension in Israel.J Neuroophthalmol2001; 21: 12–4.
30.
CraigJ.J., MulhollandD.A., GibsonJ.M.. Idiopathic intracranial hypertension: incidence, presenting features and outcome in Northern Ireland (1991–1995).Ulster Med J2001; 70: 31–5.
31.
KupersmithM.J., GamellL., TurbinR., PeckV., SpiegelP., WallM.. Effects of weight loss on the course of idiopathic intracranial hypertension in women.Neurology1998; 50: 1094–8.
32.
JohnsonL.N., KrohelG.B., MadsenR.W., MarchG.A.Jr. The role of weight loss and acetazolamide in the treatment of idiopathic intracrani al hypertension (pseudotumor cerebri).Ophthalmology1998; 105: 2313–7.
33.
CelebisoyN., SecilY., AkyurekliO.. Pseudotumor cerebri: etiological factors, presenting features and prognosis in the western part of Turkey.Acta Neurol Scand2002; 106: 367–70.
34.
WallM., HartW.M.Jr., BurdeR.M.. Visual field defects in idiopathic intracranial hypertension (pseudotumor cerebri).Am J Ophthalmol1983; 96: 654–69.
35.
PaganoR., La VecchiaC.. Overweight and obesity in Italy, 1990–91.Int J Obes1994; 18: 665–9.
36.
WilliamsonD.F.. Descriptive epidemiology of body weight and weight change in US adults.Ann Intern Med1993; 119: 646–9.
